---
bio-current:
  name-cn: 
  name_en: Xiaole Shirley Liu
  email: xsliu@jimmy.harvard.edu
  sex: 女
  birth-date: # yyyy 到年即可
  university: Harvard University 
  school: 
    - Statistics [https://statistics.fas.harvard.edu/]
    - Harvard T.H. Chan School of Public Health [https://www.hsph.harvard.edu/]
  major: 
  title: Professor
  interests: 
    - Genomics data integration and algorithm development
    - Modeling gene regulation
    - Precision cancer medicine
    - Cancer immunity and immunotherapy
  homepage: 
    - http://liulab.dfci.harvard.edu/
    - https://www.dfhcc.harvard.edu/insider/member-detail/member/xiaole-shirley-liu-phd/
    - https://www.hsph.harvard.edu/xiaole-liu/
  github: https://github.com/liulab-dfci?tab=repositories
  googlescholar: https://scholar.google.com/citations?user=8XNfVucAAAAJ&hl=zh-TW
  aminer: https://www.aminer.cn/profile/xiaole-shirley-liu/53f43690dabfaee1c0a9f031
  status: 在职
  last-update: 2021-09-09
edu-phd-1:  # 读博经历
  university: Stanford University
  school: Biomedical Informatics [https://med.stanford.edu/bmi.html]
  email: 
  date-start: 1997
  date-end: 2002
  advisor: Douglas Lee Brutlag [brutlag@stanford.edu/https://profiles.stanford.edu/douglas-brutlag]
  degree: phd
edu-phd-2:  # 读博经历
  university: Stanford University
  school: Computer Science [https://cs.stanford.edu/]
  email: 
  date-start: 1997
  date-end: 2002
  advisor: Jun S. Liu [jliu@stat.harvard.edu/http://sites.fas.harvard.edu/~junliu/]
  degree: phd minor
edu-master: # 硕士经历，没有或找不到，可不填
  university: 
  school: 
  date-start: 
  date-end: 
  advisor:
edu-bachelor-1:  # 本科经历，没有或找不到，可不填
  university: Smith College
  school: 
    - Computer Science [https://www.science.smith.edu/departments/cs/]
    - Biochemistry [https://www.smith.edu/academics/biochemistry]
  major: 
    - Computer Science
    - Biochemistry
  date-start: 1994
  date-end: 1997
edu-bachelor-2:  # 本科经历，没有或找不到，可不填
  university: Peking University
  school: Life Sciences [http://www.bio.pku.edu.cn/enhomes/index/]
  major: Biochemistry
  date-start: 1992
  date-end: 1994
page-other:   # 其他有用的链接，部分可从学者主页子栏目获得
  publication: https://liulab-dfci.github.io/publication
  research: 
  software: https://liulab-dfci.github.io/software/
  project: 
  blog: 
  arxiv: 
  linkedin: https://www.linkedin.com/in/xiaole-shirley-liu-2658a911
  weibo: 
  twitter: https://twitter.com/xshirleyliu
  wikipedia: https://en.wikipedia.org/wiki/Xiaole_Shirley_Liu
  baidu-baike:
collaboration: # 合作研究，关注学者和其他哪些学科的人合作，具体研究哪些主题
  - 
    with: # 合作者
    project: # 研究主题
  - 
    with: 
    project: 
group: # 所属团队，学者可能有不同的兴趣小组，可以列上去
job-faculty-1: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University 
  school: Statistics [https://statistics.fas.harvard.edu/]
  major: 
  email: xsliu@jimmy.harvard.edu
  homepage: https://liulab-dfci.github.io/
  date-start: 2003
  title: Professor
  type: 
job-faculty-2: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University 
  school: Harvard T.H. Chan School of Public Health [https://www.hsph.harvard.edu/]
  major: 
  email: xsliu@jimmy.harvard.edu
  homepage: https://www.hsph.harvard.edu/xiaole-liu/
  date-start: 2003
  title: Professor
  type: 
job-faculty-3: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University 
  school: Dana-Farber Cancer Institute [https://www.dfhcc.harvard.edu/]
  major: 
  email: xsliu@jimmy.harvard.edu
  homepage: https://www.dfhcc.harvard.edu/insider/member-detail/member/xiaole-shirley-liu-phd/
  date-start: 2003
  title: Professor
  type: 
job-post-doc: # 博士后研究员，字段填写参看示例文件，若无可不填写
  university: 
  school: 
  email: 
  date-start: 
  date-end: 
  advisor: 
---

# Profile

![Xiaole Shirley Liu](https://liulab-dfci.github.io/img/people/shirley_liu.png)

# Biography[English]

X Shirley Liu received a Ph.D. in Biomedical Informatics and a Ph.D. minor in Computer Science from Stanford University in 2002. She is now Professor of Biostatistics and Computational Biology at Harvard University and the Director of the Center of Functional Cancer Epigenetics at Dana-Farber Cancer Institute. Her research focuses on algorithm development and integrative mining from high throughput genomics data to understand gene regulation and therapy response in cancer.

In computational biology, her laboratory developed widely used algorithms and tools for transcription factor motif finding, ChIP-chip/seq, chromatin accessibility profiles, CRISPR screen analyses, and tumor immune characterization. Many of her algorithms helped the community adopt new genomics technologies.

In transcription and epigenetic gene regulation, Dr. Liu has been a pioneer in using chromatin dynamics to predict trans-factors and cis-elements involved in biological processes and diseases. As a member of the mod/ENCODE consortium she helped establish best practices in ChIP-chip/seq. She and colleagues generated the first high throughput nucleosome map in the human genome, and identified the chromatin signature of embryonic pluripotency. Her work significantly advanced the understanding of the roles of many transcriptional and epigenetic regulators and cis-elements in cancer.

In translational cancer research, Dr. Liu contributed to the discovery of drug response biomarkers, drug resistance mechanisms, and effective combination therapies. Through analyses of large-scale compound and genetic screens as well as tumor profiling cohorts, her group revealed the functions of steroid hormone therapies, epigenetic inhibitors, gamma secretase inhibitor, receptor tyrosine kinase inhibitors, and immune checkpoint inhibitors in different cancers.

Dr. Liu is the principal investigator of the Cancer Immune Data Common, a cancer moonshot project from National Cancer Institute with the goal of identifying biomarkers for optimizing cancer immunotherapy strategies. She is a fellow of the International Society of Computational Biology (ISCB), and a Breast Cancer Research Foundation Investigator. She is a recipient of the Sloan Research Fellowship, Weitzman Outstanding Early Career Investigator Award from the Endocrine Society, ISCB 2020 Innovator Award, and the 2020 Benjamin Franklin Award for Open Access in the Life Sciences.



# Biography[中文]

# Interests[English]

- Genomics data integration and algorithm development
- Modeling gene regulation
- Precision cancer medicine
- Cancer immunity and immunotherapy

# Interests[中文]

# Education[English]

- BA Biochemistry, BA Computer Science, 1997, Smith College

- PhD Biomedical Informatics, PhD minor Computer Science, 2002, Stanford University

# Education[中文]

# Awards[English]

She was elected a [Fellow](https://en.wikipedia.org/wiki/Fellow "Fellow") of the [International Society for Computational Biology](https://en.wikipedia.org/wiki/International_Society_for_Computational_Biology "International Society for Computational Biology") (ISCB) in 2019 for her “outstanding contributions to the fields of computational biology and [bioinformatics](https://en.wikipedia.org/wiki/Bioinformatics "Bioinformatics")”.[\[1\]](https://en.wikipedia.org/wiki/Xiaole_Shirley_Liu#cite_note-fiscb-1)

# Awards[中文]

# Talks[English]

# Talks[中文]

# Work experience[English]

- Dana-Farber Cancer Institute and Harvard School of Public Health
  - Professor of Biostatistics and Computational Biology 2012 - present
  - Associate Professor of Biostatistics and Computational Biology 2008 - 2012
  - Assistant Professor of Biostatistics and Computational Biology 2003 - 2008
  - Independent Fellow 2002 - 2003

# Work experience[中文]

# Publication[English]

- Qiu X, Feit AS, Feiglin A, Xie Y, Kesten N, Taing L, Perkins J, Gu S, Li Y, Cejas P, Zhou N, Jeselsohn R, Brown M, Shirley Liu X, Long HW. CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq Analysis. Genomics Proteomics Bioinformatics 2021. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34284136)
- Penter L, Zhang Y, Savell A, Huang T, Cieri N, Thrash EM, Kim-Schulze S, Jhaveri A, Fu J, Ranasinghe S, Li S, Zhang W, Hathaway ES, Nazzaro M, Kim HT, Chen H, Thurin M, Rodig SJ, Severgnini M, Cibulskis C, Gabriel S, Livak KJ, Cutler C, Antin JH, Nikiforow S, Koreth J, Ho VT, Armand P, Ritz J, Streicher H, Neuberg D, Hodi FS, Gnjatic S, Soiffer RJ, Liu XS, Davids MS, Bachireddy P, Wu CJ. Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood 2021. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33720354)
- Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, Meyer C, Stewig B, Xie Y, Bu X, Manos MP, Font-Tello A, Gjini E, Lako A, Lim K, Conway J, Tewari AK, Zeng Z, Das Sahu A, Tokheim C, Weirather JL, Fu J, Zhang Y, Kroger B, Liang JH, Cejas P, Freeman GJ, Rodig S, Long HW, Gewurz BE, Hodi FS, Brown M, Liu XS. Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade. 2021. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33589424)
- Tokheim C, Wang X, Timms RT, Zhang B, Mena EL, Wang B, Chen C, Ge J, Chu J, Zhang W, Elledge SJ, Brown M, Liu XS. Systematic characterization of mutations altering protein degradation in human cancers. Mol Cell 2021. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33567269)
- Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, Mathewson ND, Cartwright ANR, Cejas P, Brown M, Giobbie-Hurder A, Dillon D, Agudo J, Mittendorf EA, Liu XS, Wucherpfennig KW. Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer. Cancer Cell 2021; 39:54-67.e9. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33385331)
- Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, Boehnke K, Lynch KN, Xu R, Zarrella DT, Gu S, Cejas P, Lim K, Long HW, Elias KM, Horowitz NS, Feltmate CM, Muto MG, Worley MJ, Berkowitz RS, Matulonis UA, Nucci MR, Crum CP, Rueda BR, Brown M, Liu XS, Hill SJ. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res 2021; 81:158-173. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33158814)
- Zeng Z, Fu J, Cibulskis C, Jhaveri A, Gumbs C, Das B, Sanchez-Espiridion B, Janssens S, Taing L, Wang J, Lindsay J, Vilimas T, Zhang J, Tokheim C, Das Sahu A, Jiang P, Yan C, Duose DY, Cerami E, Chen L, Cohen D, Chen QR, Enos RA, Huang X, Lee JJ, Liu Y, Neuberg DS, Nguyen C, Patterson C, Sarkar S, Shukla SA, Tang M, Tsuji J, Uduman M, Wang X, Weirather JL, Yu J, Yu J, Zhang J, Zhang J, Meerzaman D, Thurin M, Futreal PA, Karlovich C, Gabriel SB, Wistuba II, Liu XS, Wu C. Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network. Clin Cancer Res 2021. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33323402)
- Cader FZ, Hu X, Goh WL, Wienand K, Ouyang J, Mandato E, Redd R, Lawton LN, Chen PH, Weirather JL, Schackmann RCJ, Li B, Ma W, Armand P, Rodig SJ, Neuberg D, Liu XS, Shipp MA. A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma. Nat Med 2020; 26:1468-1479. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32778827)
- Shi S, Gu S, Han T, Zhang W, Huang L, Li Z, Pan D, Fu J, Ge J, Brown M, Zhang P, Jiang P, Wucherpfennig KW, Liu XS. Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors. Clin Cancer Res 2020. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32723834)
- Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanović B, Murphy K, Wang B, Qiu X, Endress JE, Reyes J, Lim K, Font-Tello A, Syamala S, Xiao T, Reddy Chilamakuri CS, Papachristou EK, D'Santos C, Anand J, Hinohara K, Li W, McDonald TO, Luoma A, Modiste RJ, Nguyen QD, Michel B, Cejas P, Kadoch C, Jaffe JD, Wucherpfennig KW, Qi J, Liu XS, Long H, Brown M, Carroll JS, Brugge JS, Bradner J, Michor F, Polyak K. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Mol Cell 2020; 78:1096-1113.e8. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32416067)
- Abou Alaiwi S, Nassar AH, Xie W, Bakouny Z, Berchuck JE, Braun DA, Baca SC, Nuzzo PV, Flippot R, Mouhieddine TH, Spurr LF, Li YY, Li T, Flaifel A, Steinharter JA, Margolis CA, Vokes NI, Du H, Shukla SA, Cherniack AD, Sonpavde G, Haddad RI, Awad MM, Giannakis M, Hodi FS, Liu XS, Signoretti S, Kadoch C, Freedman ML, Kwiatkowski DJ, Van Allen EM, Choueiri TK. Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors. Cancer Immunol Res 2020. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32321774)

# Publication[中文]

# Information Reference

- personal website: https://liulab-dfci.github.io/
- wikipedia: https://en.wikipedia.org/wiki/Xiaole_Shirley_Liu
- homepage: https://www.dfhcc.harvard.edu/insider/member-detail/member/xiaole-shirley-liu-phd/
- aminer: https://www.aminer.cn/profile/xiaole-shirley-liu/53f43690dabfaee1c0a9f031
- Mathematics Genealogy Project: https://www.genealogy.math.ndsu.nodak.edu/id.php?id=69306

# Notes